2022 Shaoxing nucleic acid testing policy The latest news of Shaoxing nucleic acid testing price adjustment.

In order to implement the requirements of prevention and control of pneumonia in COVID-19, cooperate with large-scale screening and normalization testing, and reduce the burden on the masses and social costs, according to the Notice of Zhejiang Health and Health Committee of Zhejiang Medical Insurance Bureau on Further Reducing the Price of Nucleic Acid Testing and Antigen Testing in novel coronavirus, Shaoxing City has adjusted the price of nucleic acid testing and antigen testing in novel coronavirus since June 6.

The price of single nucleic acid detection in novel coronavirus was adjusted to 16 yuan/time; The price of mixed nucleic acid testing in novel coronavirus is 4 yuan per sample, and the medical insurance payment policy is implemented according to the Notice on Formulating and Adjusting the Price of Related Testing Items in novel coronavirus.

The price of antigen detection service is adjusted to 2 yuan/time, and antigen detection reagents are sold at zero difference rate. Charge according to the method of "antigen detection items+detection reagents", and the total charge shall not exceed 6 yuan/time. The medical insurance payment policy shall be implemented in accordance with the Notice of Zhejiang Medical Security Bureau on Doing a Good Job in Medical Security for Current Epidemic Prevention and Control.

Novel coronavirus nucleic acid detection service in public medical institutions should provide two service options: single-person single-person detection and multi-person mixed detection. Under the premise of meeting the epidemic prevention and control regulations, people who are willing to do all the tests are allowed to choose voluntarily. Social testing institutions such as non-public medical institutions and medical laboratories should follow the pricing principle of "fairness, legality, honesty and credit" in providing nucleic acid testing services in COVID-19, which embodies the principle of low capital preservation and consistent quality and price, and advocates referring to the nucleic acid testing prices of public medical institutions.

For the large-scale screening and normalization detection of government organizations, we should fully consider the scale effect and the cost-sharing effect of grassroots organizations and volunteers. COVID-19 nucleic acid mixed detection is not higher than the 3.5 yuan of each sample. If the testing organization only provides sample transfer and testing services, the charging standard needs to be further reduced.